한글목차

뼈 생물학 세계 시장 규모는 2024년 195억 8,000만 달러에 달했고, 예측 기간 동안 3.20%의 연평균 복합 성장률(CAGR)을 기록할 것으로 예상됩니다.

세계 뼈 생체공학 시장은 뼈의 치유와 재생을 촉진하도록 설계된 생물학적 제품 및 재료의 개발 및 판매를 전문으로 하는 의료 산업에서 급성장하고 있는 분야입니다. 이 제품들은 일반적으로 뼈의 성장, 수복, 유합을 촉진하는 정형외과 및 척추 수술에 사용됩니다. 세계보건기구(WHO)에 따르면, 2030년까지 60세 이상 세계 인구는 14억 명에 달할 것으로 예상되며, 2020년의 10억 명에서 2050년에는 이 인구층이 두 배인 21억 명으로 증가할 것으로 예상됩니다. 또한 80세 이상 인구는 2050년까지 3배인 4억 2,600만 명에 달할 것으로 예측됩니다.

시장 성장 촉진요인

인구 고령화

주요 시장 이슈

생산 비용

주요 시장 동향

첨단 생체재료 및 생물학적 제제

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 뼈 생물학 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(동종 이식, 골수 흡인 농축물, 뼈 형성 단백질, 탈염 뼈 매트릭스, 혈장 풍부 단백질, 합성 오소바이오로직스, 점성 보충 제품)
  • 용도별(골절 회복, 악안면 및 치과 용도, 골관절염 및 변성 관절염, 연부조직 손상, 척추고정술)
  • 최종사용자별(치과의원 및 시설, 병원, 연구 및 학술기관, 전문 클리닉, 기타)
  • 지역별
  • 기업별(2024년)
• 제품 시장 맵
  • 제품별
  • 용도별
  • 최종사용자별
  • 지역별

제6장 북미의 뼈 생물학 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 뼈 생물학 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인

제8장 아시아태평양의 뼈 생물학 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국

제9장 남미의 뼈 생물학 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 뼈 생물학 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 인수합병(M&A)
• 제품 출시

제13장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Stryker Corp
• DePuy Synthes Inc
• Medtronic PLC
• Osteomed LP
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• Genzyme Corp
• Arthrex Inc
• Orthofix International BV

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

영문목차

Global Osteobiologics Market was valued at USD 19.58 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 3.20% through 2030. The global osteobiologics market refers to a rapidly growing sector within the medical industry that specializes in the development and distribution of biological products and materials designed to enhance bone healing and regeneration. These products are commonly used in orthopedic and spinal surgical procedures to facilitate bone growth, repair, and fusion. According to World Health Organization, by 2030, the global population aged 60 years and over is projected to reach 1.4 billion, up from 1 billion in 2020. By 2050, this demographic is expected to double to 2.1 billion. Also, the population aged 80 years and older is anticipated to triple, reaching 426 million by 2050.

Key Market Drivers

Aging Population

The global healthcare landscape is experiencing a seismic shift, with one of the most significant factors being the rapidly aging population. As life expectancy increases and birth rates decline, the world is witnessing a demographic transformation. This aging demographic is not just impacting the social and economic fabric but also plays a pivotal role in shaping the healthcare industry. According to the fracture fixation, bone regeneration aims to restore stiffness and strength, ensuring the bone can bear physiological loads after a fracture. Fracture healing involves biological and mechanical mechanisms, occurring in cortical bone, intramedullary bone, periosteum, and soft tissues. Bone healing progresses through phases of inflammation, repair, and remodeling. Direct bone healing happens with minimal movement and direct apposition under compression.

With aging, the risk of orthopedic disorders such as osteoarthritis, osteoporosis, and degenerative joint diseases significantly increases. These conditions often result in fractures, joint degeneration, and the need for orthopedic surgeries. Osteobiologics, biological products that aid bone healing and regeneration, have become a vital component in the treatment of these disorders, providing an ideal environment for bone fusion and faster recovery.

Key Market Challenges

Cost of Production

The production of osteobiologic products can be expensive due to the need for advanced biotechnological processes and stringent quality control. The cost of materials and manufacturing can be a significant barrier to market entry for smaller companies and can influence product pricing, potentially limiting patient access to these innovative treatments.

Key Market Trends

Advanced Biomaterials and Biologics

The development of innovative biomaterials and biologics is at the forefront of the osteobiologics market. Researchers are creating new materials that mimic natural bone structures more closely and enhance the body's regenerative abilities. This includes 3D-printed implants, engineered growth factors, and synthetic

Key Market Players

• Stryker Corp
• DePuy Synthes Inc
• Medtronic PLC
• Osteomed LP
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• Genzyme Corp
• Arthrex Inc
• Orthofix International BV

Report Scope:

In this report, the Global Osteobiologics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Osteobiologics Market, By Product:

• Allografts
• Bone Marrow Aspirate Concentrate
• Bone Morphogenic Protein
• Demineralized Bone Matrices
• Plasma-Rich Protein
• Synthetic Orthobiologics
• Visco-Supplementation Products

Osteobiologics Market, By Application:

• Fracture Recovery
• Maxillofacial & Dental Applications
• Osteoarthritis & Degenerative Arthritis
• Soft-Tissue Injuries
• Spinal Fusion

Osteobiologics Market, By End User:

• Dental Clinics & Facilities
• Hospitals
• Research & Academic Institutes
• Specialty Clinics
• Others

Osteobiologics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Osteobiologics Market.

Available Customizations:

Global Osteobiologics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Osteobiologics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 5.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 5.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Product
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Osteobiologics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 6.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 6.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Osteobiologics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Osteobiologics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Osteobiologics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Osteobiologics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 7.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 7.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Osteobiologics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Osteobiologics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. France Osteobiologics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Osteobiologics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Osteobiologics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Osteobiologics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 8.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 8.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Osteobiologics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Japan Osteobiologics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. India Osteobiologics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Australia Osteobiologics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. South Korea Osteobiologics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Osteobiologics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 9.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 9.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Osteobiologics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Osteobiologics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Osteobiologics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Osteobiologics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, Visco-Supplementation Products)
  • 10.2.2. By Application (Fracture Recovery, Maxillofacial & Dental Applications, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Spinal Fusion)
  • 10.2.3. By End User (Dental Clinics & Facilities, Hospitals, Research & Academic Institutes, Specialty Clinics, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Osteobiologics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Osteobiologics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Osteobiologics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User
  • 10.3.4. Kuwait Osteobiologics Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Product
      • 10.3.4.2.2. By Application
      • 10.3.4.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Stryker Corp
• 14.2. DePuy Synthes Inc
• 14.3. Medtronic PLC
• 14.4. Osteomed LP
• 14.5. Zimmer Biomet Holdings, Inc.
• 14.6. Smith & Nephew plc
• 14.7. Genzyme Corp
• 14.8. Arthrex Inc
• 14.9. Orthofix International BV

15. Strategic Recommendations

16. About Us & Disclaimer